5 analysts have shared their evaluations of Insulet (NASDAQ:PODD) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 3 | 0 | 2 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 2 | 0 | 1 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 1 | 0 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $232.4, a high estimate of $250.00, and a low estimate of $220.00. This current average has increased by 1.6% from the previous average price target of $228.75.
Breaking Down Analyst Ratings: A Detailed Examination
The perception of Insulet by financial experts is analyzed through...
Login or create a forever free account to read this news
Sign up/Log in